NITI Aayog Aims to Overhaul Indian MedTech Regulations
India relies heavily on imports to equip its hospitals and clinics. Therefore, government think tank NITI Aayog recently met with stakeholders to strengthen domestic medical device manufacturing. The discussions brought together clinicians, device manufacturers, and senior health officials. Furthermore, researchers from IIT Delhi and IIT Mumbai joined the deliberation to explore practical solutions.
The high-level meeting examined regulatory obstacles, infrastructure deficits, and high production expenses. Consequently, policymakers want to align future regulations directly with India's long-term healthcare priorities.
Key Hurdles in Medical Device Manufacturing
Domestic manufacturers face significant obstacles when competing against foreign corporations. Specifically, the Association of Indian Medical Device Industry highlighted a 10 to 15 percent cost disadvantage. High power tariffs, expensive logistics, and steep capital costs drive this pricing disparity. Moreover, Indian companies struggle with limited access to risk capital and advanced testing laboratories.
Regulatory bottlenecks also impose severe burdens on emerging enterprises. For example, establishing a compliant manufacturing facility previously required about 18 months. Today, however, overlapping clearances and shifting rules stretch that timeline to nearly four years. As a result, domestic manufacturers struggle to bring life-saving technologies to clinical practice quickly.
Policy Reforms and Industry Demands
To resolve these systemic bottlenecks, industry representatives proposed several targeted interventions. Most importantly, manufacturers demanded a dedicated statute tailored specifically to medical technology. Medical hardware differs fundamentally from pharmaceutical drugs in design and risk classification. Therefore, applying rigid drug-style inspections harms engineering innovation.
In addition, stakeholders requested financial incentives and streamlined licensing procedures. Faster approvals would help domestic dental and medical equipment makers scale their operations. Furthermore, close collaboration between academic institutions and clinical practitioners will boost indigenous innovation. Consequently, these coordinated reforms can significantly reduce hospital procurement expenses across India.
Frequently Asked Questions
Q1: Why is NITI Aayog reviewing medical device policies?
The agency wants to reduce import dependence and support local production. Furthermore, it aims to eliminate severe regulatory bottlenecks that delay domestic factory launches.
Q2: What primary challenges do domestic medical device makers face?
Indian manufacturers face a 10 to 15 percent cost disadvantage. In addition, lengthy approval timelines now delay new facility setups for nearly four years.
Q3: What reforms did industry representatives propose to the government?
Industry leaders called for a dedicated medical device law rather than drug-oriented rules. Additionally, they requested faster regulatory clearances and direct financial support.
References
- NITI Aayog explores policies to boost India's medical and dental devicemanufacturing industry - ETHealthworld
- NITI Aayog Plans Medical Device Boost - India Business Trade
- Eleven associations seek health minister for urgent re-examination of Draft Drugs, Medical Devices and Cosmetics Bill - Pharmabiz.com
